Table of Contents

2019-2024 Global Carbocisteine Consumption Market Report

1 Scope of the Report

• 1.1 Market Introduction
• 1.2 Research Objectives
• 1.3 Years Considered
• 1.4 Market Research Methodology
• 1.5 Economic Indicators
• 1.6 Currency Considered

2 Executive Summary

• 2.1 World Market Overview
  • 2.1.1 Global Carbocisteine Consumption 2014-2024
  • 2.1.2 Carbocisteine Consumption CAGR by Region
• 2.2 Carbocisteine Segment by Type
  • 2.2.1 0.985
  • 2.2.2 >98.5%
• 2.3 Carbocisteine Consumption by Type
  • 2.3.1 Global Carbocisteine Consumption Market Share by Type (2014-2019)
  • 2.3.2 Global Carbocisteine Revenue and Market Share by Type (2014-2019)
  • 2.3.3 Global Carbocisteine Sale Price by Type (2014-2019)
• 2.4 Carbocisteine Segment by Application
  • 2.4.1 Oral Solution
  • 2.4.2 Tablet & Capsule
  • 2.4.3 Others
• 2.5 Carbocisteine Consumption by Application
  • 2.5.1 Global Carbocisteine Consumption Market Share by Application (2014-2019)
  • 2.5.2 Global Carbocisteine Value and Market Share by Application (2014-2019)
  • 2.5.3 Global Carbocisteine Sale Price by Application (2014-2019)

3 Global Carbocisteine by Players

• 3.1 Global Carbocisteine Sales Market Share by Players
  • 3.1.1 Global Carbocisteine Sales by Players (2017-2019)
  • 3.1.2 Global Carbocisteine Sales Market Share by Players (2017-2019)
• 3.2 Global Carbocisteine Revenue Market Share by Players
  • 3.2.1 Global Carbocisteine Revenue by Players (2017-2019)
  • 3.2.2 Global Carbocisteine Revenue Market Share by Players (2017-2019)
• 3.3 Global Carbocisteine Sale Price by Players
• 3.4 Global Carbocisteine Manufacturing Base Distribution, Sales Area, Product Types by Players
  • 3.4.1 Global Carbocisteine Manufacturing Base Distribution and Sales Area by Players
  • 3.4.2 Players Carbocisteine Products Offered
• 3.5 Market Concentration Rate Analysis
  • 3.5.1 Competition Landscape Analysis
  • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
• 3.6 New Products and Potential Entrants
• 3.7 Mergers & Acquisitions, Expansion

4 Carbocisteine by Regions

• 4.1 Carbocisteine by Regions
  • 4.1.1 Global Carbocisteine Consumption by Regions
  • 4.1.2 Global Carbocisteine Value by Regions
• 4.2 Americas Carbocisteine Consumption Growth
• 4.3 APAC Carbocisteine Consumption Growth
• 4.4 Europe Carbocisteine Consumption Growth
• 4.5 Middle East & Africa Carbocisteine Consumption Growth

5 Americas

• 5.1 Americas Carbocisteine Consumption by Countries
  • 5.1.1 Americas Carbocisteine Consumption by Countries (2014-2019)
  • 5.1.2 Americas Carbocisteine Value by Countries (2014-2019)
• 5.2 Americas Carbocisteine Consumption by Type
• 5.3 Americas Carbocisteine Consumption by Application
• 5.4 United States
• 5.5 Canada
• 5.6 Mexico
• 5.7 Key Economic Indicators of Few Americas Countries

6 APAC

• 6.1 APAC Carbocisteine Consumption by Countries
  • 6.1.1 APAC Carbocisteine Consumption by Countries (2014-2019)
  • 6.1.2 APAC Carbocisteine Value by Countries (2014-2019)
• 6.2 APAC Carbocisteine Consumption by Type
• 6.3 APAC Carbocisteine Consumption by Application
• 6.4 China
• 6.5 Japan
• 6.6 Korea
• 6.7 Southeast Asia
• 6.8 India
• 6.9 Australia
• 6.10 Key Economic Indicators of Few APAC Countries

7 Europe

• 7.1 Europe Carbocisteine by Countries
  • 7.1.1 Europe Carbocisteine Consumption by Countries (2014-2019)
  • 7.1.2 Europe Carbocisteine Value by Countries (2014-2019)
• 7.2 Europe Carbocisteine Consumption by Type
• 7.3 Europe Carbocisteine Consumption by Application
• 7.4 Germany
• 7.5 France
• 7.6 UK
• 7.7 Italy
• 7.8 Russia
• 7.9 Spain
• 7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

• 8.1 Middle East & Africa Carbocisteine by Countries
  • 8.1.1 Middle East & Africa Carbocisteine Consumption by Countries (2014-2019)
  • 8.1.2 Middle East & Africa Carbocisteine Value by Countries (2014-2019)
• 8.2 Middle East & Africa Carbocisteine Consumption by Type
• 8.3 Middle East & Africa Carbocisteine Consumption by Application
• 8.4 Egypt
• 8.5 South Africa
• 8.6 Israel
• 8.7 Turkey
• 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

• 9.1 Market Drivers and Impact
  • 9.1.1 Growing Demand from Key Regions
  • 9.1.2 Growing Demand from Key Applications and Potential Industries
• 9.2 Market Challenges and Impact
• 9.3 Market Trends

10 Marketing, Distributors and Customer

• 10.1 Sales Channel
  • 10.1.1 Direct Channels
  • 10.1.2 Indirect Channels
• 10.2 Carbocisteine Distributors
• 10.3 Carbocisteine Customer

11 Global Carbocisteine Market Forecast

• 11.1 Global Carbocisteine Consumption Forecast (2019-2024)
• 11.2 Global Carbocisteine Forecast by Regions
  • 11.2.1 Global Carbocisteine Forecast by Regions (2019-2024)
  • 11.2.2 Global Carbocisteine Value Forecast by Regions (2019-2024)
  • 11.2.3 Americas Consumption Forecast
  • 11.2.4 APAC Consumption Forecast
  • 11.2.5 Europe Consumption Forecast
  • 11.2.6 Middle East & Africa Consumption Forecast
• 11.3 Americas Forecast by Countries
  • 11.3.1 United States Market Forecast
  • 11.3.2 Canada Market Forecast
  • 11.3.3 Mexico Market Forecast
  • 11.3.4 Brazil Market Forecast
• 11.4 APAC Forecast by Countries
  • 11.4.1 China Market Forecast
  • 11.4.2 Japan Market Forecast
  • 11.4.3 Korea Market Forecast
  • 11.4.4 Southeast Asia Market Forecast
  • 11.4.5 India Market Forecast
  • 11.4.6 Australia Market Forecast
• 11.5 Europe Forecast by Countries
  • 11.5.1 Germany Market Forecast
  • 11.5.2 France Market Forecast
  • 11.5.3 UK Market Forecast
  • 11.5.4 Italy Market Forecast
  • 11.5.5 Russia Market Forecast
  • 11.5.6 Spain Market Forecast
• 11.6 Middle East & Africa Forecast by Countries
  • 11.6.1 Egypt Market Forecast
  • 11.6.2 South Africa Market Forecast
  • 11.6.3 Israel Market Forecast
  • 11.6.4 Turkey Market Forecast
  • 11.6.5 GCC Countries Market Forecast
• 11.7 Global Carbocisteine Forecast by Type
• 11.8 Global Carbocisteine Forecast by Application

12 Key Players Analysis

• 12.1 Wuhan Grand Hoyo
  • 12.1.1 Company Details
  • 12.1.2 Carbocisteine Product Offered
  • 12.1.3 Wuhan Grand Hoyo Carbocisteine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.1.4 Main Business Overview
  • 12.1.5 Wuhan Grand Hoyo News
• 12.2 Moehs Iberica
  • 12.2.1 Company Details
  • 12.2.2 Carbocisteine Product Offered
  • 12.2.3 Moehs Iberica Carbocisteine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.2.4 Main Business Overview
  • 12.2.5 Moehs Iberica News
• 12.3 Afton Pharma
  • 12.3.1 Company Details
  • 12.3.2 Carbocisteine Product Offered
  • 12.3.3 Afton Pharma Carbocisteine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.3.4 Main Business Overview
  • 12.3.5 Afton Pharma News
• 12.4 Jinshi Pharm
  • 12.4.1 Company Details
  • 12.4.2 Carbocisteine Product Offered
  • 12.4.3 Jinshi Pharm Carbocisteine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.4.4 Main Business Overview
  • 12.4.5 Jinshi Pharm News
• 12.5 Hengkang Pharma
  • 12.5.1 Company Details
  • 12.5.2 Carbocisteine Product Offered
  • 12.5.3 Hengkang Pharma Carbocisteine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.5.4 Main Business Overview
  • 12.5.5 Hengkang Pharma News
• 12.6 Globe Quimica
  • 12.6.1 Company Details
  • 12.6.2 Carbocisteine Product Offered
  • 12.6.3 Globe Quimica Carbocisteine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.6.4 Main Business Overview
  • 12.6.5 Globe Quimica News
• 12.7 Xiangyu Pharmaceutical
  • 12.7.1 Company Details
  • 12.7.2 Carbocisteine Product Offered
  • 12.7.3 Xiangyu Pharmaceutical Carbocisteine Sales, Revenue, Price and Gross Margin (2017-2019)
  • 12.7.4 Main Business Overview
  • 12.7.5 Xiangyu Pharmaceutical News

...

13 Research Findings and Conclusion

Carbocisteine (INN), also called carbocysteine (USAN), is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Carbocisteine should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions.
Carbocisteine (INN), also called carbocysteine (USAN), is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Carbocisteine should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions.

In the last several years, Global market of Carbocisteine developed steady, with an average growth rate of 5.2%. In 2016, Global Revenue of Carbocisteine is nearly 35 M USD; the actual production is about 1600 MT.

The classification of Carbocisteine includes 98.5% and >98.5%, and the sales proportion of >98.5% in 2016 is about 76.2%.

Carbocisteine is widely used to make drugs, the formal of drugs include Oral Solution, Tablet & Capsule and Other. The most proportion of Carbocisteine formal is Tablet & Capsule and the proportion in 2016 is about 74%.

China is the largest supplier of Carbocisteine, with a revenue market share nearly 46% in 2016. India is the second largest supplier of Carbocisteine, enjoying revenue market share nearly 25% in 2016.

Europe is the largest consumption place, with a consumption market share nearly 33% in 2016. Following Europe, China is the second largest consumption place with the consumption market share of 26%.

Market competition is not intense. Wuhan Grand Hoyo, Moehs Iberica, Afton Pharma, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.

According to this study, over the next five years the Carbocisteine market will register a 4.3% CAGR in terms of revenue, the global market size will reach US$ 57 million by 2024, from US$ 44 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Carbocisteine business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Carbocisteine market by product type, application, key manufacturers and key regions and countries.

This study considers the Carbocisteine value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
0.985
>98.5%
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Oral Solution
Tablet & Capsule
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Wuhan Grand Hoyo
Moehs Iberica
Afton Pharma
Jinshi Pharm
Hengkang Pharma
Globe Quimica
Xiangyu Pharmaceutical
...

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Carbocisteine consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Carbocisteine market by identifying its various subsegments.
Focuses on the key global Carbocisteine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Carbocisteine with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Carbocisteine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.